CA2560580A1 — Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway
Assigned to Pfizer Products Inc · Expires 2005-10-06 · 21y expired
What this patent protects
The present invention relates to compounds of the Formula (I) wherein R1, R2 , R3, R4, R5, R6, R7 and A are as defined. Compounds of the Formula (I) have activity inhibiting production of A.beta.-peptide. The invention also relate s to pharmaceutical compositions and methods for …
USPTO Abstract
The present invention relates to compounds of the Formula (I) wherein R1, R2 , R3, R4, R5, R6, R7 and A are as defined. Compounds of the Formula (I) have activity inhibiting production of A.beta.-peptide. The invention also relate s to pharmaceutical compositions and methods for treating diseases and disorders, for example, neurodegenerative and/or neurological disorders, e.g ., Alzheimer~s disease, in a mammal comprising compounds of the Formula (I).</S DOAB>
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.